Acrx stock forecast.

ACRX Stock Forecast. While there’s much to be desired from the market after this year, analysts remain bullish. Most recently, Cantor Fitzgerald adjusted its rating to $4 but maintained an Overweight rating. Based on current trading levels, that target sits 615% higher right now.Acelrx Pharmaceuticals (ACRX) stock price prediction is 0.42410325013043 USD. The Acelrx Pharmaceuticals stock forecast is 0.42410325013043 USD for 2024 December 02, Monday with technical analysis. Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.Forecast . Price target. 4.63 0.00 0.00%. The 2 analysts offering 1 year price forecasts for ACRX have a max estimate of — and a min estimate of —. Analyst rating. Based on 2 analysts giving stock ratings to ACRX in the past 3 months. EPS. Annual Annual Quarterly Quarterly More MoreAcelRx Pharmaceuticals (ACRX) Stock Forecast & Price Prediction. Estimation of the future price movement of AcelRx Pharmaceuticals stock, based on various factors such as historical price trends, market trends, company performance, and economic conditions.

1.49%. $75.35M. Cara Therapeutics Inc. 13.45%. $73M. ACRX | Complete AcelRx Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Planning a trip can be an exciting but challenging task. From booking accommodations to creating an itinerary, there are countless details to consider. One crucial aspect that should never be overlooked is checking the 7-day weather forecas...

Which healthcare penny stocks should the risk-tolerant crowd have on their radar right now? AcelRx Pharmaceuticals ( ACRX 3.95%) and Sundial Growers ( SNDL 4.89%) are two potential diamonds in the ...Based on 4 Wall Street analysts offering 12 month price targets for Tempest Therapeutics in the last 3 months. The average price target is $21.67 with a high forecast of $47.00 and a low forecast of $8.00. The average price target represents a 452.81% change from the last price of $3.92. Highest Price Target $47.00. Average Price Target $21.67.Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Inpixon have a median target of 586,488.00, with a high estimate of 586,488.00 and a low estimate of 586,488.00. The ...We've seen plenty of personal finance tools designed to help you track what you're spending, but web site PocketSmith is an impressive new web-based personal finance tool with an emphasis on forecasting your financial future. We've seen ple...What this means: InvestorsObserver gives Acelrx Pharmaceutica (ACRX) an overall rank of 35, which is below average. Acelrx Pharmaceutica is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 35 means that 65% of stocks appear more favorable to our system.

ACRX Analyst Estimates Stock Screener Earnings Calendar Sectors Nasdaq | ACRX U.S.: Nasdaq AcelRx Pharmaceuticals Inc. Watch list After Hours Last Updated: Sep 8, 2023 7:09 p.m. EDT Delayed...

Find real-time VTGN - Vistagen Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.

Complete Novavax Inc. stock information by Barron's. View real-time NVAX stock price and news, along with industry-best analysis.Acasti Pharma Inc. (ACST) share price prediction for 2023, 2024, 2025, 2026 and 2027. ACST one year forecast. Acasti Pharma stock monthly and weekly forecasts.May 9, 2023 · ACRX competes with other companies such as ATXI, PTIX, and PBLA. On May 9, 2023, ATXI stock remained unchanged, while PTIX stock increased by 2.06%. In contrast, PBLA stock decreased by 21.71%. ACRX is set to report its next earnings on May 11, 2023. ACRX operates in the health technology sector and is involved in the major pharmaceuticals ... Stock Price Forecast The 2 analysts offering 12-month price forecasts for Acurx Pharmaceuticals Inc have a median target of 11.50, with a high estimate of 13.00 and a low estimate of 10.00.Find the latest Energizer Holdings, Inc. (ENR) stock quote, history, news and other vital information to help you with your stock trading and investing.Acme United Corporation (ACU) share price prediction for 2023, 2024, 2025, 2026 and 2027. ACU one year forecast. Acme United stock monthly and weekly forecasts.

Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Athersys Inc have a median target of 5.50, with a high estimate of 5.50 and a low estimate of 5.50. The median estimate ...Find the latest HighPeak Energy, Inc. (HPK) stock quote, history, news and other vital information to help you with your stock trading and investing.Find out why ACRX stock is a Hold. AcelRx Pharmaceuticals raised capital in December 2022, ... Management outlook to 2023 provided at the March 30, 2023 Earnings Call for fiscal 2022.The Applied Science Products, Inc. stock price gained 11.13% on the last trading day (Friday, 1st Dec 2023), rising from $4.67 to $5.19. During the last trading day the stock fluctuated 13.23% from a day low at $4.65 to a day high of $5.27. The price has risen in 6 of the last 10 days and is up by 21.26% over the past 2 weeks.14,241.02 -9.83(-0.07%) Russell 2000 1,801.15 -6.35(-0.35%) Crude Oil 75.02 -0.52(-0.69%) Gold 2,014.40 +11.40(+0.57%) Advertisement AcelRx Pharmaceuticals, Inc. (ACRX) NasdaqGM - NasdaqGM Real...

1 Wall Street research analysts have issued 1-year price objectives for Akari Therapeutics' stock. Their AKTX share price targets range from $30.00 to $30.00. On average, they predict the company's stock price to reach $30.00 in the next year. This suggests a possible upside of 906.7% from the stock's current price.Dec 1, 2023 · View AcelRx Pharmaceuticals, Inc ACRX investment & stock information. Get the latest AcelRx Pharmaceuticals, Inc ACRX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Marker Therapeutics Inc have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 40.00. The ...Find real-time NBY - NovaBay Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. A stock with insider buying, one presenting data next year, and a total dog walk into a bar... I'll keep it short and sweet. New article on KPLT LPTX…We’ve all flipped between different weather apps, wondering why each is giving a slightly different report. Before we look at AccuWeather, it’s important to understand the basics of weather forecasting. In the past, weather predictions were...Dec 1, 2023 · View AcelRx Pharmaceuticals, Inc ACRX investment & stock information. Get the latest AcelRx Pharmaceuticals, Inc ACRX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised ...Acelrx (ACRX) has received a new Buy rating, initiated by H.C. Wainwright analyst, Ed Arce. Ed Arce has given his Buy rating due to several key ...CRSP Stock 12 Months Forecast. Based on 16 Wall Street analysts offering 12 month price targets for Crispr Therapeutics AG in the last 3 months. The average price target is $85.25 with a high forecast of $220.00 and a low forecast of $42.00. The average price target represents a 21.84% change from the last price of $69.97.Find real-time ATHX:US - Athersys Inc stock quotes, company profile, news and forecasts from CNN Business.Don't miss ACRX stock next rating changes... Join Now | Login. Need Help? Call 1­-866-­796-­7386 Home; Stock Screener; Stock Ratings; Stock Portfolios; Pricing; Help; About Us « back to stock screener ACRX stock: AcelRx Pharmaceuticals Inc Current Rating. Sell. Previous Rating. Sell. Our Strong Buys double the S&P500! Learn more.

Cash Ratio forecast for AcelRx Pharmaceuticals (ACRX) stock. Annual Cash Ratio forecast for AcelRx Pharmaceuticals stock for 2021 is 1.08299256789893. It is increase 0.39% from the last annual Cash Ratio report of 1.07883329659834. Annual Cash Ratio forecast for 2022 is 1.07667132533243, and 2023 is 1.07669258943835.

Nov 29, 2023 · The AcelRx Pharmaceuticals stock price gained 3.66% on the last trading day (Wednesday, 15th Nov 2023), rising from $0.464 to $0.481. During the last trading day the stock fluctuated 11.04% from a day low at $0.450 to a day high of $0.500. The price has fallen in 6 of the last 10 days and is down by -9.09% for this period.

AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. AcelRx's lead product candidate, Niyad is a lyophilized formulation of nafamostat and is currently being studied under an investigational device exemption, or IDE ...Stock Price Forecast The 2 analysts offering 12-month price forecasts for Acurx Pharmaceuticals Inc have a median target of 11.50, with a high estimate of 13.00 and a low estimate of 10.00. Acurx Pharmaceuticals, Inc. Analyst Report: Pfizer Inc. Pfizer is a leading developer and manufacturer of pharmaceuticals and biotech drugs. Its products include oncology and immunology drugs ...Find real-time CTMX - CytomX Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Forecast . Price target. 4.63 0.00 0.00%. The 2 analysts offering 1 year price forecasts for ACRX have a max estimate of — and a min estimate of —. Analyst rating. Based on 2 analysts giving stock ratings to ACRX in the past 3 months. EPS. Annual Annual Quarterly Quarterly More MoreForecast . Price target. 4.63 0.00 0.00%. The 2 analysts offering 1 year price forecasts for ACRX have a max estimate of — and a min estimate of —. Analyst rating. Based on 2 analysts giving stock ratings to ACRX in the past 3 months. EPS. Annual Annual Quarterly Quarterly More MoreTheir ACRX share price targets range from $4.25 to $5.00. On average, they predict the company's stock price to reach $4.63 in the next twelve months. This …A stock with insider buying, one presenting data next year, and a total dog walk into a bar... I'll keep it short and sweet. New article on KPLT LPTX…2 Wall Street analysts have issued twelve-month price targets for AcelRx Pharmaceuticals' stock. Their ACRX share price targets range from $4.25 to $5.00. On average, they expect the company's share price to reach $4.63 in the next twelve months. This suggests a possible upside of 670.8% from the stock's current price.

Nov 24, 2023 · AcelRx Pharmaceuticals, Inc. (ACRX) share price prediction for 2023, 2024, 2025, 2026 and 2027. ACRX one year forecast. Acelrx Pharmaceuticals stock monthly and ... Get the latest AcelRx Pharmaceuticals Inc (ACRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Stock Price Forecast. The 2 analysts offering 12-month price forecasts for NovaBay Pharmaceuticals Inc have a median target of 6.65, with a high estimate of 9.50 and a low estimate of 3.80. The ... ACRX Business Overview. ACRX is a pharmaceutical company operating in the space of supervised medical settings, i.e. hospitals, ASCs (Ambulatory Surgical Centers), and procedural suites, such as ...Instagram:https://instagram. track your dividends app2023 corvette z06 70th anniversary editionubx stock forecastbest future options to buy today Find real-time BTAI - BioXcel Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. nvax wsjcredit union vs bank for mortgage Find the latest Energizer Holdings, Inc. (ENR) stock quote, history, news and other vital information to help you with your stock trading and investing. principle 401 Weather forecasting plays a crucial role in our daily lives, helping us plan our activities and make informed decisions. But have you ever wondered how meteorologists are able to accurately predict the weather? One of the key components in ...Nov 29, 2023 · The Inpixon stock price gained 1.45% on the last trading day (Wednesday, 29th Nov 2023), rising from $0.0621 to $0.0630. During the last trading day the stock fluctuated 6.05% from a day low at $0.0612 to a day high of $0.0649. The price has fallen in 6 of the last 10 days and is down by -11.89% for this period.